Experience

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of $500 million aggregate principal amount of Rexnord LLC’s and RBS…

Davis Polk advised the joint bookrunners and representatives of the several underwriters in connection with an SEC-registered offering of $300 million aggregate principal amount of 2…

Davis Polk advised China Cinda (HK) Holdings Company Limited (“Cinda HK”) in connection with a private placement of $545 million Regulation S guaranteed senior notes issued by Cinda HK’s…

Davis Polk advised ORIX Corporation in connection with its SEC-registered shelf takedown of $700 million aggregate principal amount of 3.250% notes due 2024. ORIX, one of Japan’s leading…

Davis Polk advised the joint book-running managers in connection with a debut Rule 144A/Regulation S offering of $400 million aggregate principal amount of 3.800% senior notes due 2047…

Davis Polk advised the joint book-running managers in connection with the initial public offering of 30,000,000 units of Regalwood Global Energy Ltd. for aggregate proceeds of $300…

Davis Polk is advising Aetna on its approximately $77 billion acquisition by CVS Health. The transaction, which is expected to close in the second half of 2018, is subject to approval by…

Davis Polk advised SMART Global Holdings, Inc. and certain selling shareholders in connection with an SEC-registered secondary offering of 3,261,102 ordinary shares by certain of SMART’s…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Johnson Controls International plc of €750 million aggregate principal amount of its…

Davis Polk advised the underwriter in connection with the $45.2 million SEC-registered secondary offering of 5,579,978 shares of common stock of Ardmore Shipping Corporation. The…